Ophthalmic Drugs Market 2021 In Deep Analysis, Expert Reviews and Healthcare Outlook 2025

The Global Ophthalmic Drugs Market Report provides a study with an in-depth overview, describing the product/industry Scope and elaborates market outlook and status (2021-2025). The report is curated after in-depth research and analysis by experts. The report provides comprehensive valuable insights on the global Ophthalmic Drugs market development activities demonstrated by industry players, growth opportunities, and market sizing with analysis by key segments, leading and emerging players, and geographies.

The Ophthalmic Drugs Market is expected to register a CAGR of nearly 4.6% during the forecast period.

(Exclusive Offer: Flat 25% discount on this report)

Click the link to Get a Free Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/07202152896/ophthalmic-drugs-market-growth-trends-and-forecasts-2020-2025/inquiry?mode=69

Top Companies in the Global Ophthalmic Drugs Market: Aerie Pharmaceuticals Inc., Abbive (Allergan), Bausch Health, Bayer AG, F. Hoffmann-La Roche Ltd, Hoya Corporation, Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

Market Overview:

The increasing prevalence of eye diseases is increasing the demand for ophthalmic drugs, globally. In many developed and developing countries, eye conditions have emerged as potential threats to the status of sight of their populations. The increase in the prevalence of diabetes in various countries has caused diabetic retinopathy to be added to the priority list. Glaucoma, an eye disease known for centuries, remains on the public health agenda due to difficulties in its early diagnosis and frequent necessity of life-long treatment. According to the WHO, in 2018, it was estimated that approximately 1.3 billion people were living with some form of vision impairment, 188.5 million people had mild vision impairment, 217 million had moderate to severe vision impairment, and 36 million people are blind. Globally, the leading causes of vision impairment are uncorrected refractive errors and cataracts, and the majority of people with vision impairment are over the age of 50 years. According to the WHO, chronic eye diseases are the number one cause of vision loss, with the top two causes being unoperated cataracts and uncorrected refractive errors. The former is the leading cause in countries with low- or middle-incomes. More than 80% of the vision impairments are curable or preventable, which means that these drugs are required for the management of the diseases. Hence, the rising incidence of eye-related disorders is projecting a great impact on the growth of market studied.

Regional Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

The Asia-Pacific Segment is Expected to Account for the Fastest Growth Rate

The ophthalmic drugs market is expanding and growing, globally. The market has been witnessing exponential growth in the Asia-Pacific region. Glaucoma and tear substitute (for dry eye) drugs are the leading products in Asia-Pacific. India is likely to be among the top three pharmaceutical markets by incremental growth and the sixth-largest market, globally, in absolute size, according to the Clinical and Experimental Vision and Eye Research, India, 2018. Increase in the number of middle-class households, advancement in medical infrastructure, and the increasing penetration of health insurance in the country are likely to play a significant role in influencing this growth. According to the National Health Policy (NHP), in India, glaucoma is the leading cause of irreversible blindness with at least 12 million people having affected and nearly 1.2 million people having blinded from the disease. More than 90% of the cases of glaucoma remain undiagnosed in the country.

Inquire for Discount:

https://www.marketinsightsreports.com/reports/07202152896/ophthalmic-drugs-market-growth-trends-and-forecasts-2020-2025/discount?mode=69

Key Reasons to Purchase:
 
- To gain insightful analyses of the market and have comprehensive understanding of the global Ophthalmic Drugs market and its commercial landscape.
 
- Assess the production processes, major issues, and solutions to mitigate the development risk.
 
- To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 
- Learn about the market strategies that are being adopted by leading respective organizations.
 
- To understand the future outlook and prospects for the Ophthalmic Drugs market.

Purchase Full Report@:

https://www.marketinsightsreports.com/report/purchase/07202152896?mode=su?mode=69

We Also Offer Customization on report based on specific client Requirement:

-Free country Level analysis for any 5 countries of your choice.

-Free Competitive analysis of any 5 key market players.

-Free 40 analyst hours to cover any other data point.

Please contact our sales professional (sales@marketinsightsreports.com), we will ensure you obtain the report which works for your needs.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.